Drug Pipeline

CYB003 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06564818 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive… Major Depressive Disorder Recruiting
NCT06793397 A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder Major Depressive Disorder (MDD) Recruiting
NCT06605105 Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD… Major Depressive Disorder Enrolling by Invitation
Sponsors Running CYB003 Trials
Cybin IRL Limited (3)
Disease Areas
Depression (3)
Get alerts when CYB003 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free